Welcome to our dedicated page for Fmc news (Ticker: FMC), a resource for investors and traders seeking the latest updates and insights on Fmc stock.
FMC Corporation (NYSE: FMC) is a global agricultural sciences company focused on crop protection solutions, including biologicals, crop nutrition, and digital and precision agriculture. The FMC news feed on Stock Titan aggregates company-issued press releases and other coverage so readers can follow how this agricultural chemical manufacturer communicates its strategy, performance and product developments over time.
FMC regularly publishes earnings announcements and financial updates, including quarterly results, adjusted EBITDA and adjusted earnings per share metrics, along with commentary on regional performance in North America, Latin America, Asia and EMEA. The company also announces the timing of upcoming earnings releases and webcast conference calls, providing details for internet broadcasts and telephone access, as well as replay information.
Investors can track dividend declarations and changes to the dividend policy through FMC’s news releases, which have included both regular quarterly dividend announcements and a reduction in the quarterly dividend as part of a broader emphasis on debt reduction. The news flow also covers strategic and operational updates, such as the intention to divest the India commercial business, restructuring and cost actions, and initiatives like Project Foundation that are designed to reshape the manufacturing footprint and cost structure.
Product- and technology-related news is another key element of FMC’s disclosures. The company has reported regulatory registrations for products such as Fundatis herbicide powered by Isoflex active in Great Britain, and has highlighted the role of new active ingredients and biologicals in its growth portfolio and Plant Health business. Updates on registrations, launches and regional commercialization provide insight into FMC’s pipeline and portfolio evolution.
FMC’s news also includes leadership and governance updates, such as changes in executive roles and Board composition, and announcements that senior executives will speak at investor conferences hosted by firms like Goldman Sachs and Jefferies. For investors, analysts and others following the agricultural sciences sector, the FMC news page offers a centralized view of how the company reports its financial performance, portfolio developments and corporate actions.
FMC (NYSE: FMC) announced a regular quarterly cash dividend of $0.08 per share. The dividend is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This is a routine cash distribution to eligible shareholders.
FMC (NYSE: FMC) announced that Chairman and CEO Pierre Brondeau and CFO Andrew Sandifer will speak at the Goldman Sachs Industrials and Materials Conference on December 3, 2025 at 1:30 p.m. Eastern Time.
A live webcast of the presentation will be available at www.fmc.com/investors.
FMC (NYSE: FMC) announced that Ronaldo Pereira, president, will step down effective December 15, 2025 after 28 years with the company. The decision was reached by mutual agreement with chairman and CEO Pierre Brondeau. Pereira will remain in an advisory capacity until December 15, 2025 to support a smooth transition. Management praised Pereira's leadership, citing transformation of grower relationships in Latin America and business growth in North America.
The company emphasized continuity through the agreed transition timeline and internal coordination.
FMC (NYSE:FMC) reported Q3 2025 revenue of $542M, down 49% year-over-year, driven by one-time commercial actions in India as the business is held for sale. Excluding India, revenue was $961M, down 10% versus prior year and 11% organically. GAAP net loss was $569M (loss per diluted share $4.52) after ~$510M of India-related charges and write-downs. Adjusted EBITDA was $236M (+17% YoY) and adjusted EPS was $0.89 (+30% YoY). Full-year guidance was lowered: revenue to $3.92B–$4.02B, Adjusted EBITDA to $830M–$870M, adjusted EPS to $2.92–$3.14, and free cash flow to negative $200M–$0. Quarterly dividend reduced to $0.08 to prioritize debt reduction.
FMC Corporation (NYSE: FMC) has scheduled its third quarter 2025 earnings release for Wednesday, October 29, 2025, after market close. The company will host a webcast conference call the following day, Thursday, October 30, 2025, at 9:00 a.m. ET.
The earnings call will be accessible via internet broadcast and telephone, with both U.S. local and toll-free numbers available. A replay will be available from 11:00 a.m. ET on October 30 until November 6, 2025, through both internet and telephone access.
FMC Corporation (NYSE: FMC) announced that three of its top executives will present at the upcoming Jefferies Industrials Conference. Chairman and CEO Pierre Brondeau, President Ronaldo Pereira, and Executive VP and CFO Andrew Sandifer will speak on September 3, 2025, at 7:30 a.m. ET. Investors can access the live webcast through the company's investor relations website at www.fmc.com/investors.
FMC Corporation (NYSE: FMC) has secured registration for Fundatis® herbicide in Great Britain for winter wheat and winter barley applications. The herbicide, powered by Isoflex® active, is classified as a Group 13 herbicide by HRAC and combines two previously unavailable active ingredients in Great Britain.
Fundatis® herbicide effectively controls key annual grass weeds like Blackgrass and Italian Ryegrass, along with broadleaf weeds such as Groundsel and Speedwell. The product will be available during the fall growing season in Great Britain. Isoflex® active has already been registered in several countries including Argentina, Australia, Brazil, and China, with a pending application in the European Union.
FMC Corporation (NYSE:FMC) reported Q2 2025 results with revenue of $1.05 billion, up 1% year-over-year and 2% organically. The company posted adjusted EBITDA of $207 million (up 2%) and adjusted EPS of $0.69 (up 10%). Notably, FMC announced plans to divest its India commercial business while maintaining manufacturing operations there.
The company maintained its full-year 2025 guidance with adjusted EBITDA of $870-950 million and adjusted EPS of $3.26-3.70. Revenue outlook excluding India is set at $4.08-4.28 billion, down 2% at midpoint versus 2024. Free cash flow forecast remains at $200-400 million, reflecting a 51% decline at midpoint from prior year.
Regional performance varied with EMEA showing strong growth (+29%), while Asia declined (-17%) and North America decreased (-5%). The company's growth portfolio increased by high-single digits.
FMC Corporation (NYSE: FMC) has announced its board of directors has declared a regular quarterly dividend of $0.58 per share. The dividend will be paid on October 16, 2025, to shareholders of record at the close of business on September 30, 2025.
FMC Corporation (NYSE: FMC) has received regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of its fluindapyr technology in the EMEA region. The approval covers applications for oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.
Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, providing a dual mode of action that targets diseases including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The product has already been successfully commercialized in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval in the Philippines.
The company plans to expand the availability of fluindapyr-based products to Bolivia, Chile, Colombia, Honduras, and India, pending regulatory approvals.